SANUWAVE Health, Inc. (OTCBB: SNWV) today announced that the U.S. Patent and Trademark Office (USPTO) has issued the Company patent number 8,092,401, titled "Method and Apparatus for Producing Shock Waves for Medical Applications." The patent has a term extending to February 2027 and relates to a new method of producing shock waves utilizing a mechanically pressurized fluid.
In conventional methods to produce an acoustic shock wave, the acoustic wave is triggered by an electrical impulse. By contrast, the novel method presented in this patent is mechanical and comprises oscillating high pressure generated in the encapsulated fluid within the treatment applicator, which is used to produce focused acoustic shock waves. This innovation may create efficiencies in design, manufacture and usability of the Company's Pulsed Acoustic Cellular Expression (PACE®) technology and allows for unique device configurations and clinical applications that were not previously possible.
"We are pleased to be awarded this new patent as it has potential to be a significant asset in our product development efforts," stated Christopher M. Cashman, President and CEO of SANUWAVE. "This method of producing acoustic shock waves is different from the electrohydraulic method we use in our current products, and it could give rise to new clinical indications and alternative regulatory pathways for future product offerings."